Source link : https://www.newshealth.biz/health-news/glp-1s-show-no-increased-risk-for-thyroid-cancer/
In the largest study of its kind involving a diabetic population, the use of glucagon-like peptide 1 receptor agonist (GLP-1 RA) drugs shows no significantly increased risk for thyroid cancer, with the important caveat of the study’s relatively short follow-up period. “In this large multisite study utilizing data from 6 population-based databases, we found no […]
Author : News Health
Publish date : 2025-01-16 07:06:50
Copyright for syndicated content belongs to the linked Source.
inHealth